Claris IPO is a Rs 300.00 crore book-built issuance. Claris initial public offering (IPO) bidding began on November 24, 2010 and was completed on December 2, 2010. On December 20, 2010, the shares were listed on the BSE. Claris IPO pricing range is $228 to $235 per share. An application requires a minimum lot size of 22 shares. Retail investors must make a minimum investment of $5,170.
Claris Lifesciences Limited (CLL) is an Ahmedabad-based pharmaceutical firm that was founded in 1994. Claris is India’s largest sterile injectable pharmaceutical company, with a global presence in 76 countries. Claris has 113 products across various markets and therapeutic areas. All of these items are non-patentable. Claris product portfolio includes anesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition, and cancer. Companies with a substantial presence in Latin America, the Middle East, Africa,
and Central, South, and Far East Asia generate more than half of their revenues. Claris manufacturing facilities are in Ahmedabad, India, and have received approval from foreign regulatory bodies. ISO 9001-2000 and WHO GMP certifications have been obtained for the manufacturing facilities.
Claris IPO Details
|IPO Date||November 24, 2010 to December 2, 2010|
|Listing Date||December 20, 2010|
|Face Value||₹10 per share|
|Price Band||₹228 to ₹235 per share|
|Lot Size||22 Shares|
|Total Issue Size||12,632,477 shares
(aggregating up to ₹300.00 Cr)
|Issue Type||Book Built Issue IPO|
Claris IPO Lot Size
Claris IPO Reservation
|Investor Category||Shares Offered||Maximum Allottees|
|Anchor Investor Shares Offered||–||NA|
|QIB Shares Offered||4,572,152 (51.67%)||NA|
|NII (HNI) Shares Offered||1,069,192 (12.08%)|
|Retail Shares Offered||3,207,577 (36.25%)||145,798|
|Total Shares Offered||8,848,921 (100%)|
Objects of the Issue (Claris IPO Objectives)
The objects of the issue are:
- Setting up a new plant comprises a small volume parenteral line, a PVC bag line, a non-PVC bag line, and a fat emulsion line.
- Setting up a new manufacturing line for propofol and other fat emulsion products at our existing plant, Clarion IV.
- Construction of a facility for research and development at our Clarion manufacturing facilities.
- Prepayment of an identified term loan
- General corporate purposes.
Claris Company Financials
|Particulars For the year/period ended (in Rs. million)||31-Dec-09||31-Dec-08||31-Dec-07||31-Dec-06||31-Dec-05|
|Profit After Tax (PAT)||1,303.80||1,083.95||832.72||466.93||179.30|
Claris IPO Listing Details
|Listing Date||December 20, 2010|
|BSE Script Code||533288|
|Final Issue Price||₹228 per share|
Claris Listing Day Trading Information
|Final Issue Price||₹228.00|
Claris IPO FAQs:
Q1. What is the Claris IPO?
Ans. Claris IPO is a main-board IPO of 12,632,477 equity shares with a face value of ₹10, aggregating up to ₹300.00 crore. The issue is priced at ₹228 to ₹235 per share. The minimum order quantity is 22 shares. The IPO opens on November 24, 2010, and closes on December 2, 2010. Link Intime India Private Ltd. is the registrar for the IPO. The shares are proposed to be listed on the BSE.
Q2. When will the Claris IPO go public?
Ans. The Claris IPO opens on November 24, 2010 and closes on December 2, 2010.
Q3. What is the size of the Claris IPO?
Ans. Claris IPO lot size is 22 shares, and the minimum amount required is ₹5,170.
Q4. When is the Claris IPO allotment?
Ans. The finalization of the basis of allotment for Claris IPO will be done on [.], and the allotted shares will be credited to your demat account by [.].
Q5. When is the Claris IPO listing date?
Ans. The Claris IPO listing date is on December 20, 2010.